TP53 and cancer: Furthermore, from the testing TCGA cohort, our analysis revealed that the m6Ascore was significantly different among the classification subgroups (including IDH1 mutation status, TP53 mutation status, cancer subtype classification, gender and age) (Figures 7A,B).